ArticleJournal of cellular and molecular medicine2026
RETRACTION: Long Non-Coding RNA FEZF1-AS1 Induced Progression of Ovarian Cancer via Regulating miR-130a-5p/SOX4 Axis.
Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionZ. Sun, S. Gao, L. Xuan, and X. Liu, "Long Non-Coding RNA FEZF1-AS1 Induced Progression of Ovarian Cancer via Regulating miR-130a-5p/SOX4 Axis," Journal of Cellular and Molecular Medicine 24, no. 7 (2020): 4275-4285. https://doi.org/10.1111/jcmm.15088. The above article, published online on 05 March 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu; and John Wiley & Sons Ltd. A third party reported multiple instances of image duplications between this article and previously published articles. All images in Figure 2C had previously been published in [Zhu et al. 2019 (https://doi.org/10.1038/s41467-023-41612-z)] and reported as different samples. All images in Figures 3A, 3B, 4C, and 4D had previously been published in Li et al. 2017 [(https://doi.org/10.1038/cddis.2017.119)] and reported as different samples. The GAPDH band in Figure 5D and all bands in Figure 5H had previously been published in [Liu et al. 2017 (https://doi.org/10.1186/s12943-017-0625-8)] and all those images were manipulated and rotated. Furthermore, multiple images in Figure 5E had previously been published in Liu et al. 2017, where further manipulation and rotation had been applied to these images. An investigation by the publisher confirmed these concerns and discovered additional instances of image duplication from other articles. Data in Figure 2D had previously been published in [Liang et al. 2018 (https://doi.org/10.1038/s41419-018-0582-1)], [Wang et al. 2019 (https://doi.org/10.18632/aging.102081)] and [Liang et al. 2020 (https://doi.org/10.1186/s12943-020-01206-5)]. Images in Figure 2C had previously been published in [Zhu et al. 2019 (https://doi.org/10.1038/s41467-018-07998-x)] and these images had been rotated. Multiple images in Figure 5E that were also previously published in Liu et al. 2017, were also later published in [Li et al. 2021 (https://doi.org/10.2147/OTT.S302800)]. The retraction has been agreed to because the evidence of image re-use and manipulation with multiple previously published articles fundamentally compromises the editors' confidence in the results presented. The authors did not respond to our notice regarding the retraction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.